Tuesday, 14 July 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 14 July 2026
Ascott 2
Ascott 2
Latest News
Is the Pharma Rep dead? Not a chance

Repeated speculation that the Pharma Rep is dead, couldn't be further from the truth with a survey of Australian doctors revealing just five per cent want to see less of pharma field teams. Opinions on digital content were another big surprise.

Who's bested two Big Pharmas?
Swedish rare disease specialist beat out giants Roche and Novo Nordisk to be named the best by this cohort of patients
TODAY
Shortage of chemo drugs extended
Pharma notifies TGA that shortages of its chemotherapies, which started in March are set to continue, some until mid-December
TODAY
Medscape
Medscape
Most Popular
Redundancy fears grip pharma
Industry coaching expert reveals growing stress among pharma professionals as redundancies roll out across industry
13 July
Ex-J&J leader lands CEO role
Gemma Hudson has taken a new leadership role covering Australia and New Zealand during a "significant time" for the industry
13 July
Novartis settles case with Zeller
Company announces a legal case against its former ANZ Country President launched in March has been resolved out of court
10 July
Butler fires a delisting warning shot
Minister sends a message loud and clear to both PBAC and two pharmas as public pressure mounts over feared PBS delisting
9 July
Swipe/NEXT
Swipe/NEXT
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (23)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (3)

Other (10)

More News
New player moves into CSL patch
Sydney facility ready for TGA assessment as this company prepares to enter a market long dominated by the Aussie giant
13 July
20yr road to approval finally ends
A treatment previously available only via special access has officially been registered in Australia, ending a 20-year wait
13 July
Four drugs hit with first copycats
TGA approves the first generics of four drugs, one targeting a $233M brand while another steps into a space where the originator has left
13 July
Doctors name fave vax makers
HCPs have dramatically increased support for vaccine manufacturers, but now pharma needs to adapt their messaging to a changed environment
10 July
General Managers on the move
ICYMI: More senior leadership changes with one GM appointed while another departs plus the other popular stories this week
10 July
Which company has the best MSLs?
Although the race was neck-and-neck, one company came out on top, according to a survey of oncologists in the US
10 July
Next up: a weight loss implant
First there were injections, then pills. Now Novo Nordisk is taking convenience for patients to the next level with weight loss implants
10 July
Star shines light on RSV risk
GSK teams up with well-known actress to raise awareness about the dangers of RSV for older Australians
10 July
GM tells why it was time to resign
In a heartfelt goodbye, this country leader has spoken about the personal "sliding door moment" that led to her decision to leave
9 July
Lilly, patient group invest $680K
Eli Lilly Australia and a well-known patient group have joined forces to improve digital health solutions for complex care
9 July
'Yes' with a price cut, patient cap
MSAC has supported public funding for a blood drug but with heavy conditions, just days after knocking back another new medicine
9 July
Ex-Pfizer HQ verging on collapse
Support columns inside the company's former global headquarters in New York City have buckled, sparking immediate evacuations
9 July
Another GM gone, successor named
Yet another company has announced the departure of its General Manager, with a replacement already named
8 July
Extra leave coming to pharma?
Gen Z already makes up a third of the workforce and they already hold a crucial bargaining chip in workplace negotiations
8 July
PiF Advertise
PiF Advertise
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe